Literature DB >> 31625475

Nano-enhanced Optical Gene Delivery to Retinal Degenerated Mice.

Subrata Batabyal1, Sivakumar Gajjeraman1, Sulagna Bhattacharya1, Weldon Wright1, Samarendra Mohanty1.   

Abstract

BACKGROUND: The efficient and targeted delivery of genes and other impermeable therapeutic molecules into retinal cells is of immense importance for the therapy of various visual disorders. Traditional methods for gene delivery require viral transfection, or chemical methods that suffer from one or many drawbacks, such as low efficiency, lack of spatially targeted delivery, and can generally have deleterious effects, such as unexpected inflammatory responses and immunological reactions.
METHODS: We aim to develop a continuous wave near-infrared laser-based Nano-enhanced Optical Delivery (NOD) method for spatially controlled delivery of ambient-light-activatable Muti-Characteristic opsin-encoding genes into retina in-vivo and ex-vivo. In this method, the optical field enhancement by gold nanorods is utilized to transiently permeabilize cell membrane, enabling delivery of exogenous impermeable molecules to nanorod-binding cells in laser-irradiated regions. RESULTS AND DISCUSSION: With viral or other non-viral (e.g. electroporation, lipofection) methods, gene is delivered everywhere, causing uncontrolled expression over the whole retina. This will cause complications in the functioning of non-degenerated areas of the retina. In the NOD method, the contrast in temperature rise in laser-irradiated nanorod-attached cells at nano-hotspots is significant enough to allow site-specific delivery of large genes. The in-vitro and in-vivo results using NOD, clearly demonstrate in-vivo gene delivery and functional cellular expression in targeted retinal regions without compromising the structural integrity of the eye or causing immune response.
CONCLUSION: The successful delivery and expression of MCO in the targeted retina after in-vivo NOD in the mice models of retinal degeneration opens a new vista for re-photosensitizing retina with geographic atrophies, such as in dry age-related macular degeneration. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  NOD method; Ocular gene therapy; dry-AMD; macular degeneration; optical delivery; optogenetics.

Year:  2019        PMID: 31625475      PMCID: PMC7258984          DOI: 10.2174/1566523219666191017114044

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  60 in total

1.  Phase-sensitive optical coherence tomography imaging of the tissue motion within the organ of Corti at a subnanometer scale: a preliminary study.

Authors:  Ruikang K Wang; Alfred L Nuttall
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

2.  Spectral-domain optical coherence phase microscopy for quantitative phase-contrast imaging.

Authors:  Chulmin Joo; Taner Akkin; Barry Cense; Boris H Park; Johannes F de Boer
Journal:  Opt Lett       Date:  2005-08-15       Impact factor: 3.776

3.  Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells.

Authors:  Shutao Wang; Kuan-Ju Chen; Ting-Hsiang Wu; Hao Wang; Wei-Yu Lin; Minori Ohashi; Pei-Yu Chiou; Hsian-Rong Tseng
Journal:  Angew Chem Int Ed Engl       Date:  2010-05-17       Impact factor: 15.336

4.  Optical coherence tomography difference maps and average macular volume for geographic atrophy.

Authors:  Josh Wallsh; Ron Gallemore
Journal:  Retin Cases Brief Rep       Date:  2015

5.  Effect of genome size on AAV vector packaging.

Authors:  Zhijian Wu; Hongyan Yang; Peter Colosi
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

6.  Tuning payload delivery in tumour cylindroids using gold nanoparticles.

Authors:  Byoungjin Kim; Gang Han; Bhushan J Toley; Chae-Kyu Kim; Vincent M Rotello; Neil S Forbes
Journal:  Nat Nanotechnol       Date:  2010-04-11       Impact factor: 39.213

7.  Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.

Authors:  Yu Cheng; Anna C Samia; Jun Li; Malcolm E Kenney; Andrew Resnick; Clemens Burda
Journal:  Langmuir       Date:  2010-02-16       Impact factor: 3.882

8.  Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration.

Authors:  Pamela S Lagali; David Balya; Gautam B Awatramani; Thomas A Münch; Douglas S Kim; Volker Busskamp; Constance L Cepko; Botond Roska
Journal:  Nat Neurosci       Date:  2008-04-27       Impact factor: 24.884

9.  Normal central retinal function and structure preserved in retinitis pigmentosa.

Authors:  Samuel G Jacobson; Alejandro J Roman; Tomas S Aleman; Alexander Sumaroka; Waldo Herrera; Elizabeth A M Windsor; Lori A Atkinson; Sharon B Schwartz; Janet D Steinberg; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

Review 10.  Lipid Nanoparticles for Ocular Gene Delivery.

Authors:  Yuhong Wang; Ammaji Rajala; Raju V S Rajala
Journal:  J Funct Biomater       Date:  2015-06-08
View more
  1 in total

1.  Layer-specific nanophotonic delivery of therapeutic opsin-encoding genes into retina.

Authors:  Subrata Batabyal; Sanghoon Kim; Weldon Wright; Samarendra Mohanty
Journal:  Exp Eye Res       Date:  2021-01-28       Impact factor: 3.770

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.